Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$8.11 - $11.11 $376,871 - $516,281
-46,470 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$9.85 - $17.69 $17.5 Million - $31.4 Million
-1,776,311 Reduced 97.45%
46,470 $489,000
Q4 2020

Jan 29, 2021

BUY
$14.15 - $17.19 $3.11 Million - $3.77 Million
219,528 Added 13.69%
1,822,781 $28.2 Million
Q3 2020

Oct 28, 2020

BUY
$14.14 - $19.71 $5.08 Million - $7.08 Million
359,042 Added 28.86%
1,603,253 $23.4 Million
Q2 2020

Jul 28, 2020

BUY
$16.6 - $25.25 $3.3 Million - $5.02 Million
198,663 Added 19.0%
1,244,211 $23.6 Million
Q1 2020

Apr 30, 2020

BUY
$14.38 - $27.72 $7.83 Million - $15.1 Million
544,295 Added 108.59%
1,045,548 $20.1 Million
Q4 2019

Jan 29, 2020

SELL
$9.23 - $19.67 $9.19 Million - $19.6 Million
-995,330 Reduced 66.51%
501,253 $9.61 Million
Q3 2019

Oct 31, 2019

BUY
$5.66 - $11.85 $115,175 - $241,135
20,349 Added 1.38%
1,496,583 $14.4 Million
Q2 2019

Jul 31, 2019

SELL
$4.32 - $6.43 $137,635 - $204,859
-31,860 Reduced 2.11%
1,476,234 $8.84 Million
Q1 2019

May 01, 2019

BUY
$4.12 - $10.25 $212,678 - $529,115
51,621 Added 3.54%
1,508,094 $8.81 Million
Q4 2018

Jan 30, 2019

BUY
$8.2 - $16.95 $6.25 Million - $12.9 Million
762,405 Added 109.85%
1,456,473 $13.6 Million
Q3 2018

Oct 31, 2018

BUY
$17.03 - $21.18 $2.26 Million - $2.81 Million
132,751 Added 23.65%
694,068 $11.8 Million
Q2 2018

Jul 31, 2018

BUY
$12.0 - $19.88 $6.74 Million - $11.2 Million
561,317 New
561,317 $9.54 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $490M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.